CD274 and non-small cell lung carcinoma: Moreover, recent studies have demonstrated that genetic characteristics, including PD-L1 associated mRNA signatures [11], immune infiltration-associated lncRNA signatures [12] and serum microRNA signatures [13], are emerging as critical prognostic elements in predicting the outcomes for NSCLC patients.